Evidence map›Paper›PMID 30069166›Full record

ArticleCost effectiveness and resource allocation : C/E2018

Empirical estimation of resource constraints for use in model-based economic evaluation: an example of TB services in South Africa.

Fiammetta M Bozzani, Don Mudzengi, Tom Sumner, Gabriela B Gomez, Piotr Hippner, Vicky Cardenas, Salome Charalambous, Richard White, Anna Vassall

Open access · goldAbstract read
In one paragraph

Article in Cost effectiveness and resource allocation : C/E, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Informing Balanced Investment in Services and Health Systems: A Case Study of Priority Setting for Tuberculosis Interventions in South Africa.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Improving the quality of modelling evidence used for tuberculosis policy evaluation.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Fiammetta M Bozzani1Department of Global Health and Development, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH UK.
Don Mudzengi2The Aurum Institute, Johannesburg, South Africa.
Tom Sumner3TB Modelling Group, TB Centre, CMMID, London School of Hygiene & Tropical Medicine, London, UK.
Gabriela B Gomez1Department of Global Health and Development, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH UK.
Piotr Hippner2The Aurum Institute, Johannesburg, South Africa.
Vicky Cardenas2The Aurum Institute, Johannesburg, South Africa.
Salome Charalambous3TB Modelling Group, TB Centre, CMMID, London School of Hygiene & Tropical Medicine, London, UK.
Richard White3TB Modelling Group, TB Centre, CMMID, London School of Hygiene & Tropical Medicine, London, UK.
Anna Vassall1Department of Global Health and Development, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH UK.
London School of Hygiene & Tropical Medicine · GBAurum Institute · ZA

Funding

Medical Research Council MR/P002404/1
6 · The paper itself

Abstract

backgroundEvidence on the relative costs and effects of interventions that do not consider 'real-world' constraints on implementation may be misleading. However, in many low- and middle-income countries, time and data scarcity mean that incorporating health system constraints in priority setting can be challenging.

methodsWe developed a 'proof of concept' method to empirically estimate health system constraints for inclusion in model-based economic evaluations, using intensified case-finding strategies (ICF) for tuberculosis (TB) in South Africa as an example. As part of a strategic planning process, we quantified the resources (fiscal and human) needed to scale up different ICF strategies (cough triage and WHO symptom screening). We identified and characterised three constraints through discussions with local stakeholders: (1) financial constraint: potential maximum increase in public TB financing available for new TB interventions; (2) human resource constraint: maximum current and future capacity among public sector nurses that could be dedicated to TB services; and (3) diagnostic supplies constraint: maximum ratio of Xpert MTB/RIF tests to TB notifications. We assessed the impact of these constraints on the costs of different ICF strategies.

resultsIt would not be possible to reach the target coverage of ICF (as defined by policy makers) without addressing financial, human resource and diagnostic supplies constraints. The costs of addressing human resource constraints is substantial, increasing total TB programme costs during the period 2016-2035 by between 7% and 37% compared to assuming the expansion of ICF is unconstrained, depending on the ICF strategy chosen.

conclusionsFailure to include the costs of relaxing constraints may provide misleading estimates of costs, and therefore cost-effectiveness. In turn, these could impact the local relevance and credibility of analyses, thereby increasing the risk of sub-optimal investments.

Indexed as

ConstraintsEconomic evaluationHealth systemsMathematical modellingSouth AfricaTuberculosis

Identifiers

PMID30069166
PMCPMC6065151
OpenAlexW2887639941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.